Preparation and Characterization of New Liposomes. Bactericidal Activity of Cefepime Encapsulated into Cationic Liposomes

Abstract

Cefepime is an antibiotic with a broad spectrum of antimicrobial activity. However, this antibiotic has several side effects and a high degradation rate. For this reason, the preparation and characterization of new liposomes that are able to encapsulate this antibiotic seem to be an important research line in the pharmaceutical industry. Anionic and cationic liposomes were prepared and characterized. All cationic structures contained the same cationic surfactant, N,N,N-triethyl-N-(12-naphthoxydodecyl)ammonium. Results showed a better encapsulation-efficiency percentage (EE%) of cefepime in liposomes with phosphatidylcholine and cholesterol than with 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). The presence of cholesterol and the quantity of egg-yolk phospholipid in the liposome increased the encapsulation percentage. The bactericidal activity against Escherichia coli of cefepime loaded into liposomes with phosphatidylcholine was measured. The inhibitory zone in an agar plate for free cefepime was similar to that obtained for loaded cefepime. The growth-rate constant of E. coli culture was also measured in working conditions. The liposome without any antibiotic exerted no influence in such a rate constant. All obtained results suggest that PC:CH:12NBr liposomes are biocompatible nanocarriers of cefepime that can be used in bacterial infections against Escherichia coli with high inhibitory activity.

Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations

“…3-The low loading capacity of liposomes compromises the liposomal usage as antibiotic delivery agent. This challenge can be solved by maximizing electrostatic attractions between liposomes and oppositely charged antibiotic molecules [49,50]. 4-Special sterilization techniques are needed due to the sensitivity of lipids to high temperatures [51].…”

Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy

“…The particle size of liposomes is within an optimal size range for retention of nano-carrier into the tumor tissue ( Figure 2 C). The polydispersity index (PDI) for liposomes was around 0.17 for liposome preparations, suggesting the homogeneity of liposomes [ 26 ]. Zeta potential for Dox-LP was −4.18 mV, and for SA-5-Dox-LP was −13.38 mV ( Figure 2 D).…”

Self-Assembly of Amphiphilic Compounds as a Versatile Tool for Construction of Nanoscale Drug Carriers

“…Mixed liposomes based on L-α-phosphatidylcholine and SHP-n-Q showed long-term stability (1 year) and prolonged release of rhodamine B. A cationic surfactant, N,N,N-triethyl-N-(12-naphthoxydodecyl)ammonium, was inserted in liposomes based on phosphatidylcholine [ 224 ]. Modified liposomes loaded with cefepime antibiotic can be used in bacterial infections against Escherichia coli with high inhibitory activity.…”